Poland: Crohn's and ankylosing spondylitis patients face 623-day treatment waits despite eligibility

Polish patients with Crohn's disease and active ankylosing spondylitis are experiencing extreme delays—up to 623 and 556 days respectively—in starting therapy, even though treatment is already approved and funded in drug programs. The bottleneck appears to be systemic capacity or administrative inefficiency, not eligibility or reimbursement. This highlights a paradox in Poland's healthcare system where approved therapies are inaccessible in practice, potentially worsening patient outcomes and straining public trust.